Article
Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.
Journal of immunology (Baltimore, Md. : 1950) - 1 Jan 2009
Kariuki Silvia N, Kirou Kyriakos A, MacDermott Emma J, Barillas-Arias Lilliana, Crow Mary K, Niewold Timothy B
Abstract excerpt
Increased IFN-alpha signaling is a primary pathogenic factor in systemic lupus erythematosus (SLE). STAT4 is a transcription factor that is activated by IFN-alpha signaling, and genetic variation of STAT4 has been associated with risk of SLE and rheumatoid arthritis. We measured serum IFN-alpha activity and simultaneous IFN-alpha-induced gene expression in PBMC in a large SLE cohort. The risk variant of STAT4 (T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
